FOCL
NASDAQEDAP TMS S.A.
EDAP TMS S.A. (FOCL) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company listed on NASDAQ. In the last 30 days Quantisnow tracked 4 wire items for FOCL, including 2 SEC filings, 1 press release or news item and 1 earnings update. The most recent was published Nov 5, 2026.
Financial highlights
Full financials- Revenue, TTM
- $87.53M
- Net income, TTM
- -$37.49M
- Net margin
- -42.8%
- Cash
- $56.27M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks4+100%
2026-05-172026-11-08
Mix490d
- SEC Filings2(50%)
- Other1(25%)
- Earnings1(25%)
Activity · 52 weeks42 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
4 items- SECSEC Form 10-Q filed by EDAP TMS S.A.10-Q - EDAP TMS SA (0001041934) (Filer)
- SECEDAP TMS S.A. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - EDAP TMS SA (0001041934) (Filer)
- PRFocalTherics™ Reports Third Quarter 2026 Financial ResultsFocalTherics™ Reports Third Quarter 2026 Financial Results 45% Revenue Increase and 44% Growth in U.S. Procedure Volume Year-to-date AUSTIN, Texas, Nov. 05, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ:FOCL) (the "Company"1), a global leader in robotic focal therapy, today announced financial results for the third quarter of 2026. Third Quarter 2026 Results and Recent Highlights Increased Revenue to $9.8 million, a 26% Increase Compared to the Prior Year Period 32% Increase in U.S. Procedure Volume over the Prior Year PeriodRecorded Seven Focal One® Capital System Sales compared to Six in the Prior Year Period, Expanded Focal One System Installed Base to 192, including 98 in the U.
- PRFocalTherics™ to Participate in Upcoming Investor ConferencesFocalTherics™ to Participate in Upcoming Investor Conferences AUSTIN, Texas, Nov. 04, 2026 (GLOBE NEWSWIRE) -- FocalTherics (NASDAQ:FOCL) (the "Company"), a global leader in robotic focal therapy, today announced that the Company will participate in the following investor conferences: UBS Global Healthcare Conference. Management is scheduled to participate in a Fireside Chat on November 10th, 2026, at 1:15 pm ET. Interested parties can access the live and archived webcast on the News/Events page of the Investors section of FocalTherics’ website at www.focalone.com. Jefferies Global Healthcare Conference in London. Management will host 1x1 meetings on November 18th, 2026. Piper Sand
FOCL FAQ
9 questionsWhat does EDAP TMS S.A. do?
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer.What is the latest news on FOCL?
In the last 30 days Quantisnow tracked 4 wire items for FOCL: 2 SEC filings, 1 press release or news item and 1 earnings update. The most recent was published on November 5, 2026.What is FOCL revenue?
EDAP TMS S.A. (FOCL) reported $87.53M of revenue for the twelve months ended Sep 30, 2026. Revenue for fiscal 2025 was $70.53M.Is FOCL profitable?
No. EDAP TMS S.A. reported a net loss of $37.49M for the twelve months ended Sep 30, 2026.How much cash and debt does FOCL have?
EDAP TMS S.A. reported $56.27M in cash and cash equivalents and $35.57M of debt on its most recent balance sheet in SEC filings.Where does FOCL stock trade?
EDAP TMS S.A. (FOCL) is listed on NASDAQ.What sector and industry is FOCL in?
EDAP TMS S.A. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.What companies are similar to FOCL?
Notable peers in the same industry include MDT (Medtronic plc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation), TMDX (TransMedics Group Inc.), AXGN (Axogen Inc.). Compare FOCL side-by-side with any of them on Quantisnow.How can I track FOCL on Quantisnow?
Quantisnow aggregates EDAP TMS S.A.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow FOCL to receive live email and push alerts on every new disclosure.